Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2019 from OUS - Department of Cardiology B (Div Med)

8 publications found

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D (2019)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996

Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE (2019)
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930

Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G (2019)
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
J Hypertens (in press)
DOI 10.1097/HJH.0000000000002021, PubMed 30624370

Kjeldsen SE, Mancia G (2019)
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results
J Hypertens, 37 (1), 6-8
DOI 10.1097/HJH.0000000000001874, PubMed 30499916

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E (2019)
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Blood Press, 1-7 (in press)
DOI 10.1080/08037051.2018.1524707, PubMed 30614275

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2019)
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists’ Collaboration (2019)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
J Hypertens, 37 (1), 16-23
DOI 10.1097/HJH.0000000000001994, PubMed 30499920

Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196

 
Page visits: 83463